通过多目标组合疗法对阿尔茨海默病模型进行最佳控制
Mingyan Dong1, Zun-Guang Guo2, Yongxin Zhang3
1School of Mathematics, North University of China, Taiyuan, 030051, Shanxi, China; School of Computer Science and Technology, North University of China, Taiyuan, 030051, Shanxi, China.
Journal of theoretical biology
|March 13, 2026
概括
多目标组合疗法通过减少有毒的粉样β oligomers (Aβo) 来有效控制阿尔茨海默病 (AD). 最佳控制模型表明,结合疗法在管理AD进展方面优于单一治疗.
科学领域:
- 神经科学是一个神经科学.
- 数学生物学 数学生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 是一种神经退行性疾病,其特征是有毒的粉样β (Aβ) 斑块积累.
- Aβ寡合体 (Aβo) 是AD病变发生过程中的关键神经毒剂.
- 目前针对阿尔茨海默氏症的单一向疗法由于疾病的多因素性质,显示出低于最佳的疗效.
研究的目的:
- 提出一个最佳的控制模型,用于Aβo动态在多目标组合疗法在AD.
- 导出一个值参数 (R0) 用于表征AD进展和疾病控制.
- 评估不同治疗策略的有效性和成本效益.
主要方法:
- 开发一个最佳的控制模型来模拟Aβo动态.
- 作为疾病值的基本繁殖数 (R0) 的导出和分析.
- 参数灵敏度分析和各种治疗策略的数值模拟.
- 成本效益分析,以比较单一疗法,组合疗法和剂量调整.
主要成果:
- 当R0 < 1时,Aβo可以保持在低稳定状态,这表明疾病控制的潜力.
- 与单一疗法相比,多目标组合疗法显示出对Aβo稳定状态的优越控制.
- 证明了最佳控制策略的存在和独特性.
- 通过调整较低剂量的三重疗法,可以保持治疗效果,同时改善成本控制.
结论:
- 多目标组合疗法代表了阿尔茨海默病治疗的有希望的趋势.
- 最佳控制模型为管理Aβo动态提供了有价值的见解.
- 这项研究支持开发用于早期AD干预的具有成本效益的组合疗法.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.7K
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
9.7K
相关概念视频
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:26Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
01:28Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
793
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
793